Abstract
Abelson murine leukemia virus–transformed cell lines have provided a critical model system for studying the regulation of B cell development. However, transformation by v-Abl blocks B cell development, resulting in the arrest of these transformants in an early pre-B cell–like state. We report here that treatment of Abelson virus–transformed pre-B cell lines with the small molecule Abl kinase inhibitor (STI571) results in their differentiation to a late pre-B cell–like state characterized by induction of immunoglobulin (Ig) light chain gene rearrangement. DNA microarray analyses enabled us to identify two genes inhibited by v-Abl that encode the Igk 3′ enhancer–binding transcription factors Spi-B and IRF-4. We show that enforced expression of these two factors is sufficient to induce germline Igk transcription in Abelson-transformed pro-B cell lines. This suggests a key role for these factors, and perhaps for c-Abl itself, in the regulated activation of Ig light chain gene rearrangement.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hardy, R.R. et al. B-cell commitment, development and selection. Immunol. Rev. 175, 23–32 (2000).
Muljo, S.A. & Schlissel, M.S. Pre-B and pre-T-cell receptors: conservation of strategies in regulating early lymphocyte development. Immunol. Rev. 175, 80–93 (2000).
Grawunder, U. et al. Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity 3, 601–608 (1995).
Yancopoulos, G.D. & Alt, F.W. Developmentally controlled and tissue-specific expression of unrearranged VH gene segments. Cell 40, 271–281 (1985).
Schlissel, M.S. & Baltimore, D. Activation of immunoglobulin κ gene rearrangement correlates with induction of germline κ gene transcription. Cell 58, 1001–1007 (1989).
Rosenberg, N., Baltimore, D. & Scher, C.D. In vitro transformation of lymphoid cells by Abelson murine leukemia virus. Proc. Natl. Acad. Sci. USA 72, 1932–1936 (1975).
Rosenberg, N. & Kincade, P.W. B-lineage differentiation in normal and transformed cells and the microenvironment that supports it. Curr. Opin. Immunol. 6, 203–211 (1994).
Jackson, P. & Baltimore, D. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J. 8, 449–456 (1989).
Pluk, H., Dorey, K. & Superti-Furga, G. Autoinhibition of c-Abl. Cell 108, 247–259 (2002).
Alt, F., Rosenberg, N., Lewis, S., Thomas, E. & Baltimore, D. Organization and reorganization of immunoglobulin genes in A-MULV-transformed cells: rearrangement of heavy but not light chain genes. Cell 27, 381–390 (1981).
Bendall, H.H., Sikes, M.L. & Oltz, E.M. Transcription factor NF-κB regulates Igλ light chain gene rearrangement. J. Immunol. 167, 264–269 (2001).
Schlissel, M.S., Corcoran, L.M. & Baltimore, D. Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobulin gene rearrangement and transcription. J. Exp. Med. 173, 711–720 (1991).
Klug, C.A. et al. The v-abl tyrosine kinase negatively regulates NF-κB/Rel factors and blocks κ gene transcription in pre-B lymphocytes. Genes Dev. 8, 678–687 (1994).
Chen, Y.Y., Wang, L.C., Huang, M.S. & Rosenberg, N. An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement. Genes Dev. 8, 688–697 (1994).
Schlissel, M., Constantinescu, A., Morrow, T., Baxter, M. & Peng, A. Double-strand signal sequence breaks in V(D)J recombination are blunt, 5′-phosphorylated, RAG-dependent, and cell cycle regulated. Genes Dev. 7, 2520–2532 (1993).
Stanhope-Baker, P., Hudson, K.M., Shaffer, A.L., Constantinescu, A. & Schlissel, M.S. Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro. Cell 85, 887–897 (1996).
Hoffmann, R., Seidl, T., Neeb, M., Rolink, A. & Melchers, F. Changes in gene expression profiles in developing B cells of murine bone marrow. Genome Res. 12, 98–111 (2002).
Chen, J., Ma, A., Young, F. & Alt, F.W. IL-2 receptor α chain expression during early B lymphocyte differentiation. Int. Immunol. 6, 1265–1268 (1994).
Rolink, A., Grawunder, U., Winkler, T.H., Karasuyama, H. & Melchers, F. IL-2 receptor α chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int. Immunol. 6, 1257–1264 (1994).
Zou, X., Lin, Y., Rudchenko, S. & Calame, K. Positive and negative regulation of c-Myc transcription. Curr. Top. Microbiol. Immunol. 224, 57–66 (1997).
Morrow, M.A., Lee, G., Gillis, S., Yancopoulos, G.D. & Alt, F.W. Interleukin-7 induces N-myc and c-myc expression in normal precursor B lymphocytes. Genes Dev. 6, 61–70 (1992).
Eisenbeis, C.F., Singh, H. & Storb, U. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev. 9, 1377–1387 (1995).
Shaffer, A.L., Peng, A. & Schlissel, M.S. In vivo occupancy of the κ light chain enhancers in primary pro- and pre-B cells: a model for κ locus activation. Immunity 6, 131–143 (1997).
Sheehy, A.M. & Schlissel, M.S. Overexpression of RelA causes G1 arrest and apoptosis in a pro-B cell line. J. Biol. Chem. 274, 8708–8716 (1999).
Paddison, P.J. & Hannon, G.J. RNA interference: the new somatic cell genetics? Cancer Cell 2, 17–23 (2002).
Grandori, C., Mac, J., Siebelt, F., Ayer, D.E. & Eisenman, R.N. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J. 15, 4344–4357 (1996).
Corcoran, A.E., Riddell, A., Krooshoop, D. & Venkitaraman, A.R. Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature 391, 904–907 (1998).
Marshall, A.J., Fleming, H.E., Wu, G.E. & Paige, C.J. Modulation of the IL-7 dose-response threshold during pro-B cell differentiation is dependent on pre-B cell receptor expression. J. Immunol. 161, 6038–6045 (1998).
Rolink, A., Grawunder, U., Haasner, D., Strasser, A. & Melchers, F. Immature surface Ig+ B cells can continue to rearrange κ and λ L chain gene loci. J. Exp. Med. 178, 1263–1270 (1993).
Banerjee, A. & Rothman, P. IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling. J. Immunol. 161, 4611–4617 (1998).
Perkins, E.J. et al. Sensing of intermediates in V(D)J recombination by ATM. Genes Dev. 16, 159–164 (2002).
Brown, L. & McCarthy, N. DNA repair. A sense-abl response? Nature 387, 450–451 (1997).
Jiang, D., Lenardo, M.J. & Zuniga-Pflucker, C. p53 prevents maturation to the CD4+CD8+ stage of thymocyte differentiation in the absence of T cell receptor rearrangement. J. Exp. Med. 183, 1923–1928 (1996).
Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T. & Mulligan, R.C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153–1163 (1991).
Schwartzberg, P.L. et al. Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell 65, 1165–1175 (1991).
Hardin, J.D. et al. Bone marrow B lymphocyte development in c-abl-deficient mice. Cell. Immunol. 165, 44–54 (1995).
Kruh, G.D. et al. A novel human gene closely related to the abl proto-oncogene. Science 234, 1545–1548 (1986).
Koleske, A.J. et al. Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron 21, 1259–1272 (1998).
Druker, B.J. et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 344, 1031–1037 (2001).
Rao, S., Matsumura, A., Yoon, J. & Simon, M.C. SPI-B activates transcription via a unique proline, serine, and threonine domain and exhibits DNA binding affinity differences from PU.1. J. Biol. Chem. 274, 11115–11124 (1999).
Su, G.H. et al. Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B. EMBO J. 16, 7118–7129 (1997).
Dahl, R., Ramirez-Bergeron, D.L., Rao, S. & Simon, M.C. Spi-B can functionally replace PU.1 in myeloid but not lymphoid development. EMBO J. 21, 2220–2230 (2002).
Scott, E.W., Simon, M.C., Anastasi, J. & Singh, H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265, 1573–1577 (1994).
Garrett-Sinha, L.A. et al. PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction. Immunity 10, 399–408 (1999).
Matsuyama, T. et al. Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res. 23, 2127–2136 (1995).
Pongubala, J.M. et al. PU.1 recruits a second nuclear factor to a site important for immunoglobulin κ 3′ enhancer activity. Mol. Cell Biol. 12, 368–378 (1992).
Eisenbeis, C.F., Singh, H. & Storb, U. PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin λ 2-4 enhancer. Mol. Cell Biol. 13, 6452–6461 (1993).
Brass, A.L., Zhu, A.Q. & Singh, H. Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers. EMBO J. 18, 977–991 (1999).
Mittrucker, H.W. et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275, 540–543 (1997).
Xu, Y., Davidson, L., Alt, F.W. & Baltimore, D. Deletion of the Igκ light chain intronic enhancer/matrix attachment region impairs but does not abolish VκJκ rearrangement. Immunity 4, 377–385 (1996).
Gorman, J.R. et al. The Igκ 3′ enhancer influences the ratio of Igκ versus Igλ B lymphocytes. Immunity 5, 241–252 (1996).
Lewis, S., Rosenberg, N., Alt, F. & Baltimore, D. Continuing κ-gene rearrangement in a cell line transformed by Abelson murine leukemia virus. Cell 30, 807–816 (1982).
Shinkai, Y. et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855–867 (1992).
Eisen, M.B., Spellman, P.T., Brown, P.O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863–14868 (1998).
Grogan, J.L. et al. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14, 205–215 (2001).
Han, S. et al. V(D)J recombinase activity in a subset of germinal center B lymphocytes. Science 278, 301–305 (1997).
DeKoter, R.P., Lee, H.J. & Singh, H. PU.1 Regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 16, 297–309 (2002).
Acknowledgements
We thank R.Tjian, R. Freiman, M. Holmes and Y. Isogai (HHMI, Berkeley) for use of and help with equipment required for the Affymetrix experiments; C. Lowell (UCSF) and C. Sawyers (UCLA) for assistance; N. Rosenberg, C. Guidos, F. Alt and D. Baltimore for cell lines; H. Singh (HHMI, Chicago) for Spi-B and IRF-4 cDNAs; L-Y. Hsu for designing the quantitative RT-PCR assay for Rag1 and Rag2 and J. Curry for help with the analysis; H. Nolla (Cancer Research Lab, UC Berkeley) for cell sorting; and members of the Schlissel Lab as well as A. Winoto and C. Thompson for useful comments on the manuscript. Supported by grants from the NIH (RO1 HL48702) and the Arthritis Foundation (to M.S.S.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Web Fig. 1.
Flow cytometric analyses of CD25/IL2Rα and CD62L/L-selectin cell surface expression in STI571-treated 220-8 pro-B cells. Cell surface expression of CD25 and CD62L were analyzed by flow cytometry using either PE-conjugated anti-CD25 or anti-CD62L monoclonal antibodies. The data were gated for live cells based on forward and side scatter. Top panel shows anti-CD25 staining of 220-8 cells treated with 10 μM STI571 for 12 hours (unshaded) overlaid with the histogram for untreated 220-8 (shaded dark). Bottom panel shows anti-CD62L staining of 220-8 cells treated with 10 μM STI571 for 12 hours (unshaded) overlaid with the histogram for untreated 220-8 (shaded dark). (PDF 19 kb)
Rights and permissions
About this article
Cite this article
Muljo, S., Schlissel, M. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus–transformed pre-B cell lines. Nat Immunol 4, 31–37 (2003). https://doi.org/10.1038/ni870
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni870
This article is cited by
-
An Igh distal enhancer modulates antigen receptor diversity by determining locus conformation
Nature Communications (2023)
-
AGO2 silences mobile transposons in the nucleus of quiescent cells
Nature Structural & Molecular Biology (2023)
-
Loop extrusion mediates physiological Igh locus contraction for RAG scanning
Nature (2021)
-
Regeneration of immunocompetent B lymphopoiesis from pluripotent stem cells guided by transcription factors
Cellular & Molecular Immunology (2021)
-
Radiofrequency EMF irradiation effects on pre-B lymphocytes undergoing somatic recombination
Scientific Reports (2021)